Global Cancer Immunotherapy Market Overview: 2025-2030

Base Year: 2024

Historical Years:  2020–23

Forecast Years: 2025-2030

The Global Cancer Immunotherapy Market size was valued at around USD 134.4 billion in 2024 and is projected to reach USD 214.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.12% during the forecast period, i.e., 2025-30. The Global Cancer Immunotherapy Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.

Markntel Advisor’s Global Cancer Immunotherapy Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Cancer Immunotherapy Market drivers, barriers, Global Cancer Immunotherapy Market Trends, and Key Players in Global Cancer Immunotherapy Market.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/global-cancer-immunotherapy-market.html

Global Cancer Immunotherapy Market Dynamics: 2025-2030

Global Cancer Immunotherapy Market Driver:

Increasing Frequency of Approvals Received by Novel Immunotherapies - Increasing acceptance of novel immunotherapies is expected to bode well for market expansion in the coming years. For instance, The U.S. FDA authorized a number of anti-PD-1/L1 antibodies between 2020 and 2022 for the treatment of NSCLC, renal cell carcinoma, melanoma, breast, prostate, and other malignancies. These antibodies include nivolumab, atezolizumab, avelumab, dostarlimab, and others. Therefore, the increased approval of immunotherapeutic drugs has fueled market development in the past few years.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/global-cancer-immunotherapy-market.html

Global Cancer Immunotherapy Market (2025-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Product Type

-Monoclonal Antibodies

-Immunomodulators

-Oncolytic Viral Therapies and Cancer Vaccines

-Checkpoint Inhibitors

-Others

By Cancer Type

-Lung Cancer

-Prostate Cancer

-Breast Cancer

-Ovarian Cancer

-Pancreatic Cancer

-Head and Neck Cancer

-Melanoma

-Colorectal Cancer

(The lung cancer segment is the leading cancer type in the global cancer immunotherapy market by revenue and market share.)

By Mechanism of Actions

-Active Immunotherapy

-Passive Immunotherapy

By End Users

-Hospitals

-Cancer Research Centers

-Clinics

By Region

-North America

-Latin America

-Europe

-Middle East and Africa

-Asia-Pacific.

(North America led the overall market in terms of revenue owing to the presence of numerous key players and the various strategic initiatives they have undertaken.)

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Cancer Immunotherapy Market:

-Amgen Inc.,

-Astrazeneca,

-Bayer AG,

-Bristol-Myers Squibb,

-ELI Lilly and Company,

-Janssen Global Services LLC

-Johnson and Johnson),

-Merck,

-Novartis,

-Pfizer, F.

-F. Hoffmann-La Roche AG.

Industry Recent Development:

In 2024: AstraZeneca decided to pay USD 18 million to Immunai (biotechnology firm) to use New York-based firm’s AI model of the immune system for cancer drug trials.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India